glp-1 dual agonist GIPR/GLP-1R therapies for diabetes and weight loss– Chemistry, Physiology and Clinical application Evaluation of biased agonism mediated
Description
They stimulate insulin secretion and inhibit glucagon secretion by elevating endogenous GLP-1 concentrations without an intrinsic hypoglycaemia risk
Despite major advances in understanding GLP-1R function, a better understanding in the relative implication of these distinct pathways in physiological functions may help the development of improved therapeutics
Make sure your insurance will approve the medication if your doctor prescribes a GLP-1 agonist
Symptoms include shakiness, sweating, confusion, rapid heartbeat, and in severe cases, loss of consciousness
